Home/Filings/4/0001127602-14-034762
4//SEC Filing

ALLERGAN INC 4

Accession 0001127602-14-034762

CIK 0000850693operating

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 6:52 PM ET

Size

7.2 KB

Accession

0001127602-14-034762

Insider Transaction Report

Form 4
Period: 2014-12-08
Transactions
  • Award

    Phantom Stock Units

    2014-12-09$212.40/sh+5.89$1,2517,430.95 total
    Common Stock (5.89 underlying)
  • Award

    Phantom Stock Units

    2014-12-08$212.56/sh+7.06$1,5017,425.06 total
    Common Stock (7.06 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program.
  • [F3]Phantom stock units are to be settled 100% in common stock upon the Reporting Person's retirement as an Allergan, Inc. director.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000850693

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 6:52 PM ET
Size
7.2 KB